SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses

American Journal of Translational Research

Volumn 5, Issue 4, 2013, Pages 427-440

  Yang, Ping ^a   Zhang, Yushan ^b   Xu, Junfa ^c   Zhang, Shu ^a   Yu, Qilin ^a   Pang, Junfeng ^b   Rao, Xiaoquan ^b   Kuczma, Michal ^b   Marrero, Mario B ^b   Fulton, David ^b   Kraj, Piotr ^b   Su, Yunchao ^b   Wang, Cong Yi ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial cells; SUMO1; Sumoylation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PROTEIN C JUN; SUMO 1 PROTEIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA TRANSCRIPTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SOUTHERN BLOTTING; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

MUS MUSCULUS; SUS;

EID: 84878312204     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wilson VG and Rosas-Acosta G. Wrestling with SUMO in a new arena. Sci STKE 2005; 2005: pe32.
2. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, Zeidler A, Raffel LJ, Jacob CO, Park Y, Serrano-Rios M, Larrad MT, Zhang Z, Garchon HJ, Bach JF, Rotter JI, She JX and Wang CY. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004; 36: 837-841.
3. Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX and Wang CY. SUMO wrestling with type 1 diabetes. J Mol Med (Berl) 2005; 83: 504-513.
4. Sarge KD and Park-Sarge OK. Sumoylation and human disease pathogenesis. Trends Biochem Sci 2009; 34: 200-205.
5. Gao C, Ho CC, Reineke E, Lam M, Cheng X, Stanya KJ, Liu Y, Chakraborty S, Shih HM and Kao HY. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Mol Cell Biol 2008; 28: 5658-5667.
6. Pan MR, Chang TM, Chang HC, Su JL, Wang HW and Hung WC. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. J Cell Sci 2009; 122: 3358-3364.
7. Woo CH, Shishido T, McClain C, Lim JH, Li JD, Yang J, Yan C and Abe J. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ Res 2008; 102: 538-545.
8. Woo CH and Abe J. SUMO--a post-translational modification with therapeutic potential? Curr Opin Pharmacol 2010; 10: 146-155.
9. Su Y, Cao W, Han Z and Block ER. Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain. Am J Physiol Lung Cell Mol Physiol 2004; 287: L794-800.
10. Zhong J, Yang P, Muta K, Dong R, Marrero M, Gong F and Wang CY. Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS One 2010; 5: e9593.
11. Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, Purohit S, Dong Z, Wang MH, She JX, Gong F, Stern DM and Wang CY. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 2008; 57: 2118-2127.
12. Rao X, Zhong J, Zhang S, Zhang Y, Yu Q, Yang P, Wang MH, Fulton DJ, Shi H, Dong Z, Wang D and Wang CY. Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation 2011; 123: 2964-2974.
13. Zhang S, Zhong J, Yang P, Gong F and Wang CY. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol 2009; 3: 24-38.
14. Zhang S, Lv JW, Yang P, Yu Q, Pang J, Wang Z, Guo H, Liu S, Hu J, Li J, Leng J, Huang Y, Ye Z and Wang CY. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol 2012; 181: 937-946.
15. Wang CY, Yang P, Li M and Gong F. Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity. Biochem Biophys Res Commun 2009; 381: 477-481.
16. Guo D, Han J, Adam BL, Colburn NH, Wang MH, Dong Z, Eizirik DL, She JX and Wang CY. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun 2005; 337: 1308-1318.
17. Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP and Casola A. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J Biol Chem 2004; 279: 2461-2469.
18. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2007; 9: 731-739.
19. Yang X, Qiao D, Meyer K and Friedl A. Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res 2009; 69: 1668-1677.
20. Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Higaki J, Yasufumi K and Ogihara T. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 2000; 86: 974-981.
21. Wang N, Verna L, Hardy S, Zhu Y, Ma KS, Birrer MJ and Stemerman MB. c-Jun triggers apoptosis in human vascular endothelial cells. Circ Res 1999; 85: 387-393.
22. Ulrich HD. The SUMO system: an overview. Methods Mol Biol 2009; 497: 3-16.
23. Manza LL, Codreanu SG, Stamer SL, Smith DL, Wells KS, Roberts RL and Liebler DC. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem Res Toxicol 2004; 17: 1706-1715.
24. Yang W, Sheng H, Warner DS and Paschen W. Transient global cerebral ischemia induces a massive increase in protein sumoylation. J Cereb Blood Flow Metab 2008; 28: 269-279.
25. Alkuraya FS, Saadi I, Lund JJ, Turbe-Doan A, Morton CC and Maas RL. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 2006; 313: 1751.
26. Zhang FP, Mikkonen L, Toppari J, Palvimo JJ, Thesleff I and Janne OA. Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol 2008; 28: 5381-5390.
27. Hanahan D and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
28. Munoz-Chapuli R, Quesada AR and Angel Medina M. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 2004; 61: 2224-2243.
29. Li JJ and Johnson AR. Selective MMP13 inhibitors. Med Res Rev 2011; 31: 863-894.
30. Nisato RE, Hosseini G, Sirrenberg C, Butler GS, Crabbe T, Docherty AJ, Wiesner M, Murphy G, Overall CM, Goodman SL and Pepper MS. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res 2005; 65: 9377-9387.
31. Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, D'Armiento J and Okada Y. MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 2009; 175: 533-546.
32. Lederle W, Hartenstein B, Meides A, Kunzelmann H, Werb Z, Angel P and Mueller MM. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 2010; 31: 1175-1184.
33. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E and Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002; 277: 36288-36295.
34. Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M, Deryugina EI and Quigley JP. Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 2004; 279: 27633-27645.
35. Dudley AC, Thomas D, Best J and Jenkins A. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem J 2005; 390: 427-436.
36. Tritsaris K, Myren M, Ditlev SB, Hubschmann MV, van der Blom I, Hansen AJ, Olsen UB, Cao R, Zhang J, Jia T, Wahlberg E, Dissing S and Cao Y. IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc Natl Acad Sci U S A 2007; 104: 15364-15369.
37. Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ and Peppelenbosch MP. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 2004; 94: 1032-1040.
38. Yasuda Y, Fujita Y, Masuda S, Musha T, Ueda K, Tanaka H, Fujita H, Matsuo T, Nagao M, Sasaki R and Nakamura Y. Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 2002; 23: 1797-1805.
39. Desterro JM, Rodriguez MS and Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2: 233-239.
40. Kisseleva T, Song L, Vorontchikhina M, Feirt N, Kitajewski J and Schindler C. NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer. J Clin Invest 2006; 116: 2955-2963.
41. Zhang G, Dass CR, Sumithran E, Di Girolamo N, Sun LQ and Khachigian LM. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J Natl Cancer Inst 2004; 96: 683-696.